Connection
Kristen Nadeau to Glucagon-Like Peptide 1
This is a "connection" page, showing publications Kristen Nadeau has written about Glucagon-Like Peptide 1.
|
|
Connection Strength |
|
 |
|
 |
|
0.190 |
|
|
|
-
Tell SS, Schafer M, Vigers T, Baumgartner AD, Lyon E, Gross S, Polsky S, Snell-Bergeon JK, Schauer IE, Nadeau KJ. Bromocriptine quick-release as adjunct therapy in youth and adults with type 1 diabetes: A randomized, placebo-controlled crossover study. Diabetes Obes Metab. 2022 11; 24(11):2148-2158.
Score: 0.190